From gene therapy to salivary gland regeneration, NIDCR-supported scientists aim to restore saliva flow for people with diseased or damaged glands.
NIDCR News 2023
NIDCR issued 26 awards, totaling $14.1 million, as part of three bold new initiatives to tackle unsolved clinical challenges related to head and neck cancer, temporomandibular disorders, and practice-based dental research.
Decades of NIDCR research has expanded understanding of temporomandibular disorders and orofacial pain in general.
Patients and scientists celebrated the 25-year legacy of NIDCR research on fibrous dysplasia/McCune-Albright syndrome and shared their hopes for the future.
An international clinical trial suggests that early surgery for isolated cleft palate is more likely to benefit a child's speech.
NIDCR congratulates former institute grantee Dr. Drew Weissman for being a co-recipient of the 2023 Nobel Prize in Physiology or Medicine.
An experimental drug, encaleret, showed promise for treating autosomal dominant hypocalcemia type 1 in an NIDCR-led trial. The rare genetic disorder, marked by low blood calcium levels, can cause symptoms from muscle cramps to life-threatening seizures.
NIDCR researchers made an unexpected discovery that helps to answer a long-standing mystery tied to a group of stem cells that are key to vertebrate development.
NIDCR held a symposium on June 27, 2023, to kick off its year-long 75th anniversary celebration.
What shapes our faces? Decades’ worth of NIDCR research is enabling scientists to crack the code of facial appearance and craniofacial conditions.
NIDCR began its slate of 75th anniversary events on March 17, 2023, with a symposium called “Scientific Strides of the NIDCR: 75 Years and Beyond.”